Gabapentin
Product Images NDC 67046-238

10 FDA label images from Contract Pharmacy Services-pa · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Gabapentin (NDC 67046-238). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Contract Pharmacy Services-pa, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (54f184de Ba3e 4db8 Ae88 B4c06263df79 01)

Image (54f184de Ba3e 4db8 Ae88 B4c06263df79 01)
A table titled 'Gabapentin Dosage Based on Renal Function' listing dose ranges and regimens in mg/day based on creatinine clearance levels, including post-hemodialysis supplemental doses. It provides dosage adjustments for patients with varying renal function and notes on dosing frequency abbreviations (TID, BID, QD).*
FDA Label Image

Image (54f184de Ba3e 4db8 Ae88 B4c06263df79 02)

Image (54f184de Ba3e 4db8 Ae88 B4c06263df79 02)
A mathematical formula for calculating creatinine clearance (CLCr) based on age, weight, serum creatinine, and a gender adjustment factor. This text is often found in medical or pharmacological dosing information panels.*
FDA Label Image

Image (54f184de Ba3e 4db8 Ae88 B4c06263df79 03)

Image (54f184de Ba3e 4db8 Ae88 B4c06263df79 03)
A data table titled 'TABLE 2 Risk by Indication for Antiepileptic Drugs in the Pooled Analysis' presenting risk statistics for various indications including Epilepsy, Psychiatric, and Other. It compares events per 1000 patients between placebo and drug patients, relative risk, and risk differences expressed as additional drug patients with events per 1000 patients.*
FDA Label Image

Image (54f184de Ba3e 4db8 Ae88 B4c06263df79 04)

Image (54f184de Ba3e 4db8 Ae88 B4c06263df79 04)
Chemical structure diagram of gabapentin showing a cyclohexane ring attached to an amino group (CH2NH2) and a carboxyl group (CH2CO2H).*
FDA Label Image

Image (54f184de Ba3e 4db8 Ae88 B4c06263df79 05)

Image (54f184de Ba3e 4db8 Ae88 B4c06263df79 05)
A line graph depicting mean pain scores over an 8-week period comparing placebo and Gabapentin 3600 mg/day. The x-axis shows weeks, divided into a 4-week dose titration period and a 4-week fixed dose period, while the y-axis shows mean pain scores from 0 to 10. Gabapentin shows a downward trend in pain scores over time compared to the placebo group.*
FDA Label Image

Image (54f184de Ba3e 4db8 Ae88 B4c06263df79 06)

Image (54f184de Ba3e 4db8 Ae88 B4c06263df79 06)
Line chart depicting mean pain scores over a 7-week period comparing placebo and Gabapentin treatments at 1800 mg/day and 2400 mg/day. The x-axis represents weeks from baseline to week 7, while the y-axis shows mean pain scores. The chart includes a 3-week dose titration period followed by a 4-week fixed dose period.*
FDA Label Image

Image (54f184de Ba3e 4db8 Ae88 B4c06263df79 07)

Image (54f184de Ba3e 4db8 Ae88 B4c06263df79 07)
Bar chart titled 'Proportion of Responders (patients with ≥ 50% reduction in pain score) at Endpoint: Controlled PHN Studies' shows comparison between placebo (PBO) and Gabapentin (GBP) dosages in two studies. Study 1 compares PBO and GBP 3600 mg, with responder rates of 12% and 29%, respectively. Study 2 compares PBO, GBP 1800 mg, and GBP 2400 mg, with responder rates of 14%, 32%, and 34%, respectively. Statistical significance indicators are included for GBP versus PBO.*
FDA Label Image

Image (54f184de Ba3e 4db8 Ae88 B4c06263df79 08)

Image (54f184de Ba3e 4db8 Ae88 B4c06263df79 08)
A scatter plot chart showing percentage difference versus daily dose in mg for gabapentin across three studies labeled a, b, and c. The x-axis represents daily dose ranging from 600 to 1800 mg, and the y-axis shows difference in percentage from 2% to 22%. Data points for each study are plotted with different symbols and colors as indicated in the legend.*
FDA Label Image

Image (54f184de Ba3e 4db8 Ae88 B4c06263df79 09)

Image (54f184de Ba3e 4db8 Ae88 B4c06263df79 09)
Label of Gabapentin 600 mg tablets, package of 30, labeled by Contract Pharmacy Services-PA. The label indicates 'Rx Only,' includes lot and expiration information, barcodes, and storage instructions at 20°-25°C (68°-77°F). It states each tablet contains 600 mg gabapentin USP and refers to the package insert for full prescribing information.*
FDA Label Image

Image (54f184de Ba3e 4db8 Ae88 B4c06263df79 10)

Image (54f184de Ba3e 4db8 Ae88 B4c06263df79 10)
Gabapentin 800 mg tablets packaging label showing a quantity of 30 tablets. The label includes storage instructions to keep at 20°-25°C (68°-77°F), barcodes, the lot number H605341, pill ID 13, and expiration date 04/13/18. Packaged by Contract Pharmacy Services-PA with address in Warrington, PA. The label references prescribing information in the package insert and states each tablet contains 800 mg of gabapentin USP.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.